# FDA Inspection 1010013 - Emerson Hospital - April 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/emerson-hospital/44fcfda6-276d-4cff-b8d2-8f275f67cccc
Source feed: FDA_Inspections

> FDA Inspection 1010013 for Emerson Hospital on April 13, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010013
- Company Name: Emerson Hospital
- Inspection Date: 2017-04-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1277644 - 2025-08-06](https://www.keypedia.com/records/fda_inspections/emerson-hospital/b93241d8-d04e-4129-ab24-6b7592e95c9d)
- [FDA Inspection 1202980 - 2023-03-30](https://www.keypedia.com/records/fda_inspections/emerson-hospital/69939d4a-0b09-475c-b1ba-928d0de89600)
- [FDA Inspection 1202980 - 2023-03-30](https://www.keypedia.com/records/fda_inspections/emerson-hospital/5621d3ad-34b1-4912-8d8f-7f99b667d88a)
- [FDA Inspection 1078912 - 2019-02-04](https://www.keypedia.com/records/fda_inspections/emerson-hospital/747202e3-7931-4379-90ab-38a72a275a0c)
- [FDA Inspection 916284 - 2015-01-13](https://www.keypedia.com/records/fda_inspections/emerson-hospital/343c3524-a76a-4c99-9af8-40f11d00d163)

Company: https://www.keypedia.com/companies/emerson-hospital/f5210e72-6185-4844-a510-2da4585f63ac

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d